After analyzing the ascitic fluid samples from a total of 48 patients with epithelial ovarian cancer, Matte et al. (2012) detected elevated levels of leptin, which were associated with shorter progression-free survival. The gene discussed is LEP; the disease is ovarian carcinoma.